ARTICLE | Clinical News
Transgene starts two Phase II trials
January 23, 2002 8:00 AM UTC
TRGNY started two Phase II trials of its MVA-Muc1-IL2 vaccine to treat lung cancer and breast cancer in Switzerland, France, and Belgium. The product is a vaccinia virus that delivers the Muc1 tumor a...